최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기약학회지 = Yakhak hoeji, v.49 no.3, 2005년, pp.217 - 224
장석기 (식품의약품안전청 생명공학의약품과) , 오일웅 (식품의약품안전청 생명공학의약품과) , 정자영 (식품의약품안전청 생명공학의약품과) , 안광수 (식품의약품안전청 생명공학의약품과) , 손여원 (식품의약품안전청 생명공학의약품과)
Human Immunodeficiency Virus type 1 (HIV-l) based lentivirus vector has demonstrated great potential as gene therapy vectors mediating efficient gene delivery and long-term transgene expression in both dividing and nondividing cells. However, for clinical studies it must be confirmed that vector pre...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Trono, D. : Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther. 7, 20 (2000)
Naldini, L., Blomer, U., Gallay, P.. Ory, D., Mulligan. R., Gage, F. H., Verma, I. M. and Trono, D. : In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263 (1996)
VandenDriessche, T.. Thorrez, L., Naldini, L., Follenzi, A., Moons, L., Berneman, Z., Collen, D. and Chuah, M. K. : Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen- presenting cells in vivo. Blood. 100, 813 (2002)
Escarpe, P., Zayek, N., Chin, P., Borellini, F., Zufferey, R.. Veres, G. and Kiermer, V. : Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations. Mol. Ther. 8, 332 (2003)
Herry, I. S., Yoo, E. S. and Sutton, R E. : Characterization and detection of artificial replication-competent lentivirus of altered host range. Mol. Ther. 8, 118 (2003)
Enca, M. R, Linda, J. W, Anna, O., Kyriacos, A. M. and Nicholas, D. M. : New methods to titrate EIAV-based lentiviral vectors. Mol. Ter. 5, 566 (2002)
Delenda, C., Audit, M. and Danos, O. : Biosafety issues in lentivector production. Curr. Top. Microbial. Immunol. 261, 123 (2002)
Farson, D., Witt, R., McGuinness, R., Dull, T., Kelly, M., Song, J., Radeke, R., Bukovsky, A., Consiglio, A. and Naldini, L. : A new generation stable inducible packaging cell line for lentiviral vectors. Hum. Gene. Ther. 12, 981 (2001)
Sastry, L., Xu, Y., Johnson, T., Desai, K, Rissing, D., Marsh, J. and Cornetta, K. : Certification assays for HIV-1-based vectors : Frequent passage of Gag sequences without evidence of replication-competent viruses. Mol. Ther. 8, 830 (2003)
Wu, X., Wakefield, J. K., Liu, H., Xiao, H., Kralovics, R., Prchal, J. T. and Kappes, J. C. : Development of a novel trans-lentiviral vector that affords predictable safety. Mol. Ther. 2, 47 (2000)
Sastry. L., Johnson, T., Hobson, M. J., Smucker, B. and Cornetta, K. : Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther. 9, 1155 (2002)
Gatlin, J., Ohlmayer, M. I. and Garcia, J. V. : Detection and titration of lentivirus vector preparations. In Lentivirus gene engineering protocols Vol. 229, M. Federico, Humana Press. Totowa, New Jersey, p57 (2003)
Evans, J. T. and Garcia, J. V. : Lentivirus vector mobilization and spread by human immunodeficiency virus. Hum. Gene. Ther. 11, 2331 (2000)
Armin, B. : Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer. Methods 33, 164 (2004)
Guidance for industry : Supplemental guidance on testing for replication competent retrovirus in retroviral vector based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors, U.S. Department of health and human services, FDA, CBER (1999)
Wilson, C. A., Ng, T. H. and Miller, A. E. : Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vector. Hum. Gene Ther. 8, 869 (1997)
Klein, S. A., Karsten, S., Ruster, B., Klebba, C., Pape, M., Ottmann, O. G., Hoelzer, D. and Roth, W. K. : Comparison of TaqMan real-time PCR and p24 ELISA for quantification of in vitro HIV-1 replication. J. Virol. Methods 107, 169 (2003)
※ AI-Helper는 부적절한 답변을 할 수 있습니다.